influenza
viru
entri
mediat
receptor
bind
domain
rbd
spike
hemagglutinin
ha
adapt
avian
virus
human
associ
ha
specif
sialic
acid
sa
receptor
defin
mutat
influenza
subtyp
avian
ha
alter
specif
sa
either
decreas
increas
recognit
rbd
mutant
use
develop
vaccin
monoclon
antibodi
neutral
new
variant
structurebas
modif
ha
specif
guid
develop
preemptiv
vaccin
therapeut
monoclon
antibodi
evalu
emerg
humanadapt
strain
sa
specif
differ
analyz
modif
glycan
microarray
method
resialyl
ha
assay
glycan
array
coexpress
na
purifi
mutat
elimin
recognit
substrat
compar
wildtyp
protein
fig
versu
b
resialyl
ha
assay
confirm
loss
recognit
tripl
mutant
lack
bind
tabl
also
seen
analysi
previous
describ
mutant
also
reveal
recognit
tabl
final
identifi
mutat
increas
recognit
tabl
particularli
variant
alter
loop
helix
alter
specif
confirm
glycan
microarray
tabl
mutat
repres
altern
ha
adapt
substrat
recognit
lastment
instanc
increas
bind
similar
although
ident
humanadapt
influenza
virus
immunogen
antigen
differ
among
alter
receptor
specif
analyz
vaccin
mice
wildtyp
triplemut
ha
gener
monoclon
antibodi
mab
mab
recogn
mutant
wildtyp
ha
coexpress
na
differenti
specif
fig
one
potent
mab
neutral
wildtyp
show
significantli
reduc
activ
triplemut
pseudoviru
fig
left
contrast
second
monoclon
neutral
equival
maxim
inhibitori
concentr
although
smaller
differ
observ
intermedi
concentr
fig
middl
third
mab
isol
immun
triplemut
express
vector
show
convers
specif
inhibit
tripl
mutant
affect
wildtyp
pseudoviru
fig
b
c
right
final
although
effect
neutral
wild
type
anoth
antibodi
show
compar
activ
fig
confirm
differenti
antigen
mutant
modif
sa
bind
specif
therefor
alter
neutral
sensit
facilit
gener
vaccin
elicit
effect
neutral
mab
report
identifi
mutat
avian
hemagglutinin
alter
specif
sa
receptor
shown
mutant
use
elicit
neutral
monoclon
antibodi
effect
inhibit
variant
neutral
sensit
determin
lentivir
entri
assay
previous
shown
defin
mechan
entri
numer
virus
includ
hiv
sever
acut
respiratori
syndrom
sar
ebola
marburg
hemorrhag
virus
recent
influenza
inhibit
antibodi
determin
neutral
sensit
correl
hemagglutin
inhibit
tradit
marker
immun
protect
tabl
approach
specif
ha
examin
independ
molecular
adapt
requir
gener
replicationcompet
viru
allow
identif
sever
mutant
alter
sa
specif
mutant
defin
recent
whose
recognit
assess
lessspecif
assay
find
gain
recognit
ha
assay
tabl
previous
report
mutant
also
show
bind
tabl
therefor
unlik
ha
mutant
report
previous
humanadapt
although
may
repres
step
pathway
whether
acquisit
specif
would
increas
transmiss
also
remain
unknown
recent
ha
mutat
viru
allow
human
sa
recognit
shown
enhanc
transmiss
ferret
support
notion
provid
model
evalu
mutant
approach
ration
design
humanadapt
vaccin
facilit
analys
well
develop
preemptiv
countermeasur
contain
influenza
outbreak
five
major
antigen
site
ha
lie
access
surfac
adjac
rbd
although
antibodi
region
affect
rbd
specif
neutral
sensit
chang
sole
rbd
shown
alter
immunogen
structurebas
modif
rbd
specif
facilit
gener
mab
independ
major
antigen
site
direct
function
constrain
domain
may
less
readili
evolv
resist
serv
vaccin
prototyp
develop
humanadapt
strain
emerg
alter
specif
triplemut
compar
wildtyp
coexpress
na
glycan
microarray
analysi
wildtyp
b
triplemut
ha
purifi
coexpress
na
perform
modif
previou
techniqu
perform
core
h
consortium
function
genom
emori
univers
glycan
relat
linkag
group
color
select
glycoprotein
orang
predominantli
yellow
green
ligand
blue
other
purpl
previous
shown
tabl
alter
neutral
sensit
mutant
pseudoviru
bind
ha
coexpress
na
transfect
cell
determin
flow
cytometri
indic
mab
blue
isotyp
control
igg
red
b
neutral
sensit
assess
indic
mab
c
neutral
sensit
indic
wildtyp
mutant
mab
ngml
shown
nd
done
neutral
sensit
wildtyp
mutant
mab
present
tabl
specif
glycan
recognit
efficaci
entri
wildtyp
mutant
mutant
thailand
vietnam
use
describ
method
abil
indic
bind
determin
resialyl
hemagglutin
assay
mutant
loss
ha
activ
relev
control
b
previous
describ
mutant
c
mutant
increas
bind
viral
entri
wildtyp
mutant
pseudotyp
lentivir
vector
measur
describ
degre
entri
follow
wt
wt
wt
wt
ident
genbank
sequenc
differ
amino
acid
nk
yamada
colleagu
mutant
ident
accord
altern
number
convent
